NEWS
- Apr. 21, 2023
- Our disease awareness campaign for World Hemophilia Day
- Mar. 25, 2021
- KM Biologics Announces Phase I Clinical Study Results of a Live Attenuated Tetravalent Dengue Vaccine (KD-382)
- Dec. 21, 2018
- Nature, November special issue — KM Biologics: Safeguarding public health
- Oct. 31, 2018
- KM Biologics launches new website